These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31296490)

  • 1. The fragility of phase 3 trials supporting FDA-approved anticancer medicines: a retrospective analysis.
    Del Paggio JC; Tannock IF
    Lancet Oncol; 2019 Aug; 20(8):1065-1069. PubMed ID: 31296490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent fragility of randomized controlled trials for HCC treatment.
    Zhang H; Li J; Zeng W
    BMC Cancer; 2021 Apr; 21(1):389. PubMed ID: 33836710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fragility index of positive phase II and III randomised clinical trials of treatments for hepatocellular carcinoma (2002-2022).
    Sidali S; Sritharan N; Campani C; Gregory J; Durand F; Ganne-Carrié N; Ronot M; Lévy V; Nault JC
    JHEP Rep; 2023 Jul; 5(7):100755. PubMed ID: 37425214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragility index of trials supporting approval of anti-cancer drugs in common solid tumours.
    Desnoyers A; Wilson BE; Nadler MB; Amir E
    Cancer Treat Rev; 2021 Mar; 94():102167. PubMed ID: 33652263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fragility of statistically significant findings from randomized trials in spine surgery: a systematic survey.
    Evaniew N; Files C; Smith C; Bhandari M; Ghert M; Walsh M; Devereaux PJ; Guyatt G
    Spine J; 2015 Oct; 15(10):2188-97. PubMed ID: 26072464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fragility of statistically significant findings from randomised controlled trials in the urological literature.
    Narayan VM; Gandhi S; Chrouser K; Evaniew N; Dahm P
    BJU Int; 2018 Jul; 122(1):160-166. PubMed ID: 29569390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of single arm versus randomised phase 2 oncology trial characteristics with phase 3 outcome.
    Monzon JG; Hay AE; McDonald GT; Pater JL; Meyer RM; Chen E; Chen BE; Dancey JE
    Eur J Cancer; 2015 Nov; 51(17):2501-7. PubMed ID: 26338195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragility of results from randomized controlled trials supporting the guidelines for the treatment of osteoporosis: a retrospective analysis.
    Huang X; Chen B; Thabane L; Adachi JD; Li G
    Osteoporos Int; 2021 Sep; 32(9):1713-1723. PubMed ID: 33595680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Fragility Index in peri-operative randomised trials that reported significant mortality effects in adults.
    Bertaggia L; Baiardo Redaelli M; Lembo R; Sartini C; Cuffaro R; Corrao F; Zangrillo A; Landoni G; Bellomo R
    Anaesthesia; 2019 Aug; 74(8):1057-1060. PubMed ID: 31025706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Fragility of Statistically Significant Randomized Controlled Trials in Plastic Surgery.
    Chin B; Copeland A; Gallo L; Wakeham S; Coroneos CJ; Walsh M; Thoma A; Voineskos S
    Plast Reconstr Surg; 2019 Nov; 144(5):1238-1245. PubMed ID: 31688772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragility of randomized trials supporting cancer drug approvals stratified by approval pathway and review designations.
    Wilson BE; Desnoyers A; Nadler MB; Tibau A; Amir E
    Cancer Med; 2021 Aug; 10(16):5405-5414. PubMed ID: 34323019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Fragility of Statistically Significant Findings From Randomized Trials in Sports Surgery: A Systematic Survey.
    Khan M; Evaniew N; Gichuru M; Habib A; Ayeni OR; Bedi A; Walsh M; Devereaux PJ; Bhandari M
    Am J Sports Med; 2017 Jul; 45(9):2164-2170. PubMed ID: 27895038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Fragility and Reliability of Conclusions of Anesthesia and Critical Care Randomized Trials With Statistically Significant Findings: A Systematic Review.
    Grolleau F; Collins GS; Smarandache A; Pirracchio R; Gakuba C; Boutron I; Busse JW; Devereaux PJ; Le Manach Y
    Crit Care Med; 2019 Mar; 47(3):456-462. PubMed ID: 30394920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fragility of significant results underscores the need of larger randomized controlled trials in nephrology.
    Shochet LR; Kerr PG; Polkinghorne KR
    Kidney Int; 2017 Dec; 92(6):1469-1475. PubMed ID: 28754551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Results of Randomized Controlled Trials in Emergency Medicine Are Frequently Fragile.
    Brown J; Lane A; Cooper C; Vassar M
    Ann Emerg Med; 2019 Jun; 73(6):565-576. PubMed ID: 30551894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival-Inferred Fragility Index of Phase 3 Clinical Trials Evaluating Immune Checkpoint Inhibitors.
    Bomze D; Asher N; Hasan Ali O; Flatz L; Azoulay D; Markel G; Meirson T
    JAMA Netw Open; 2020 Oct; 3(10):e2017675. PubMed ID: 33095247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are results from randomized trials in anesthesiology robust or fragile? An analysis using the fragility index.
    Goerke K; Parke M; Horn J; Meyer C; Dormire K; White B; Bright T; Walters C; Vassar M
    Int J Evid Based Healthc; 2020 Mar; 18(1):116-124. PubMed ID: 31415254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The statistical significance of randomized controlled trial results is frequently fragile: a case for a Fragility Index.
    Walsh M; Srinathan SK; McAuley DF; Mrkobrada M; Levine O; Ribic C; Molnar AO; Dattani ND; Burke A; Guyatt G; Thabane L; Walter SD; Pogue J; Devereaux PJ
    J Clin Epidemiol; 2014 Jun; 67(6):622-8. PubMed ID: 24508144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Publication statuses of clinical trials supporting FDA-approved immune checkpoint inhibitors: a meta-epidemiological investigation.
    Omae K; Kataoka Y; Tsujimoto Y; Tsutsumi Y; Yamamoto Y; Fukuhara S; Furukawa TA
    BMC Cancer; 2019 Oct; 19(1):998. PubMed ID: 31651263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Fragility of Statistically Significant Results in Pediatric Orthopaedic Randomized Controlled Trials as Quantified by the Fragility Index: A Systematic Review.
    Khormaee S; Choe J; Ruzbarsky JJ; Agarwal KN; Blanco JS; Doyle SM; Dodwell ER
    J Pediatr Orthop; 2018 Sep; 38(8):e418-e423. PubMed ID: 29979332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.